US-based biotechnology company Ocugen has dosed the first subject in a multicentre Phase I trial of OCU200 for diabetic ...

MALVERN, PA, USA I January 16, 2025 I Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and ...

Alberta’s optometrists are asking the provincial government to revisit upcoming changes to vision care, which they say could ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

Israel and Hamas Work Out Differences Over Deal, Netanyahu Says Prime Minister Benjamin Netanyahu ordered a meeting of Israel’s political security cabinet to vote on the Gaza cease-fire deal. A ...

“We are not the enemy of the people. We are the defenders of the people,” Acosta told viewers Thursday night.